This Fund Just Cut a Viridian Stock Position by Over $80 Million. Here's What Investors Should Know

This clinical-stage biotech develops antibody therapies for thyroid eye disease, advancing multiple candidates through its R&D pipeline.

The 5 diseases hiding in plain sight: How to spot an autoimmune shift early

Wellness coach Ram Verma recently listed 5 diseases that are “slowly destroying our body” on a podcast. Speaking to Raj Shamani, he named “Thyroid, Rheumatoid Arthritis, Psoriasis, Diabetes 1, Lupus,” ...